BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23704323)

  • 1. Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice.
    Nagendran J; Kienesberger PC; Pulinilkunnil T; Zordoky BN; Sung MM; Kim T; Young ME; Dyck JR
    Heart; 2013 Jul; 99(14):1041-7. PubMed ID: 23704323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity.
    Pulinilkunnil T; Kienesberger PC; Nagendran J; Sharma N; Young ME; Dyck JR
    Int J Obes (Lond); 2014 Feb; 38(2):205-15. PubMed ID: 23817015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.
    Pulinilkunnil T; Kienesberger PC; Nagendran J; Waller TJ; Young ME; Kershaw EE; Korbutt G; Haemmerle G; Zechner R; Dyck JR
    Diabetes; 2013 May; 62(5):1464-77. PubMed ID: 23349479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction.
    Kienesberger PC; Pulinilkunnil T; Sung MM; Nagendran J; Haemmerle G; Kershaw EE; Young ME; Light PE; Oudit GY; Zechner R; Dyck JR
    Mol Cell Biol; 2012 Feb; 32(4):740-50. PubMed ID: 22158969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides.
    Gao H; Feng XJ; Li ZM; Li M; Gao S; He YH; Wang JJ; Zeng SY; Liu XP; Huang XY; Chen SR; Liu PQ
    Arch Biochem Biophys; 2015 Jan; 565():76-88. PubMed ID: 25436917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation.
    Kienesberger PC; Pulinilkunnil T; Nagendran J; Young ME; Bogner-Strauss JG; Hackl H; Khadour R; Heydari E; Haemmerle G; Zechner R; Kershaw EE; Dyck JR
    Cardiovasc Res; 2013 Aug; 99(3):442-51. PubMed ID: 23708736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
    Salatzki J; Foryst-Ludwig A; Bentele K; Blumrich A; Smeir E; Ban Z; Brix S; Grune J; Beyhoff N; Klopfleisch R; Dunst S; Surma MA; Klose C; Rothe M; Heinzel FR; Krannich A; Kershaw EE; Beule D; Schulze PC; Marx N; Kintscher U
    PLoS Genet; 2018 Jan; 14(1):e1007171. PubMed ID: 29320510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of doxorubicin on cardiac lipid metabolism-related transcriptome and the protective activity of Alda-1.
    da Cunha Menezes Souza L; Fernandes FH; Presti PT; Anjos Ferreira AL; Fávero Salvadori DM
    Eur J Pharmacol; 2021 May; 898():173955. PubMed ID: 33617823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
    Vandenwijngaert S; Swinnen M; Walravens AS; Beerens M; Gillijns H; Caluwé E; Tainsh RE; Nathan DI; Allen K; Brouckaert P; Bartunek J; Scherrer-Crosbie M; Bloch KD; Bloch DB; Janssens SP; Buys ES
    Antioxid Redox Signal; 2017 Feb; 26(4):153-164. PubMed ID: 27505125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
    Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
    Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac oxidative stress in a mouse model of neutral lipid storage disease.
    Schrammel A; Mussbacher M; Winkler S; Haemmerle G; Stessel H; Wölkart G; Zechner R; Mayer B
    Biochim Biophys Acta; 2013 Nov; 1831(11):1600-8. PubMed ID: 23867907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.
    Wölkart G; Schrammel A; Dörffel K; Haemmerle G; Zechner R; Mayer B
    Br J Pharmacol; 2012 Jan; 165(2):380-9. PubMed ID: 21585347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-γ in patients with triglyceride deposit cardiomyovasculopathy.
    Hirano K; Tanaka T; Ikeda Y; Yamaguchi S; Zaima N; Kobayashi K; Suzuki A; Sakata Y; Sakata Y; Kobayashi K; Toda T; Fukushima N; Ishibashi-Ueda H; Tavian D; Nagasaka H; Hui SP; Chiba H; Sawa Y; Hori M
    Biochem Biophys Res Commun; 2014 Jan; 443(2):574-9. PubMed ID: 24332944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.
    Neilan TG; Blake SL; Ichinose F; Raher MJ; Buys ES; Jassal DS; Furutani E; Perez-Sanz TM; Graveline A; Janssens SP; Picard MH; Scherrer-Crosbie M; Bloch KD
    Circulation; 2007 Jul; 116(5):506-14. PubMed ID: 17638931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-specific expression of heat shock protein 27 attenuated endotoxin-induced cardiac dysfunction and mortality in mice through a PI3K/Akt-dependent mechanism.
    You W; Min X; Zhang X; Qian B; Pang S; Ding Z; Li C; Gao X; Di R; Cheng Y; Liu L
    Shock; 2009 Jul; 32(1):108-17. PubMed ID: 19106822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose triglyceride lipase-null mice are resistant to high-fat diet-induced insulin resistance despite reduced energy expenditure and ectopic lipid accumulation.
    Hoy AJ; Bruce CR; Turpin SM; Morris AJ; Febbraio MA; Watt MJ
    Endocrinology; 2011 Jan; 152(1):48-58. PubMed ID: 21106876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
    van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
    J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Adipose Triglyceride Lipase Overexpression Protects against Burn-Induced Cardiac Lipid Accumulation and Injury.
    Li L; Zhang X; Zhang Q; Jia J; Zhang J; Zhang D; Song H; Chen B; Hu J; Huang Y
    Oxid Med Cell Longev; 2019; 2019():6428924. PubMed ID: 31223422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling identifies the novel role of immunoproteasome in doxorubicin-induced cardiotoxicity.
    Zhao WJ; Wei SN; Zeng XJ; Xia YL; Du J; Li HH
    Toxicology; 2015 Jul; 333():76-88. PubMed ID: 25896364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.